Back to search results

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Abroad (travel likely)RecruitingPHASE2

Conditions

Bladder Urothelial Carcinoma · Muscle Invasive Bladder Carcinoma · Stage II Bladder Cancer AJCC v8 · Stage IIIA Bladder Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

  • Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States

    Contact: Study coordinator (Shilpa Gupta, MD) · GUPTAS5@ccf.org · 216-444-6833
    Contact: Principal Investigator (Shilpa Gupta, MD)

  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Yuanquan Yang, MD, PhD) · Yuanquan.Yang@osumc.edu · 614-366-2485
    Contact: Principal Investigator (Yuanquan Yang, MD, PhD)
Study leads

  • Yuanquan Yang, MD, PhD

    Principal Investigator

    Ohio State University Comprehensive Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)